Top 10 Companies in the Piezoceramic Components for Medical Market (2026): Market Leaders Driving Innovation

MARKET INSIGHTS

Global Piezoceramic Components for Medical market was valued at USD 155.2 million in 2025 and is projected to reach USD 310.6 million by 2034, reflecting a steady upward trajectory driven by expanding healthcare infrastructure and increasing adoption of advanced medical devices.

Piezoceramic components harness the piezoelectric effect to convert electrical energy into precise mechanical vibrations. Their high sensitivity, durability, and ability to be miniaturised make them essential in ultrasonic surgical instruments, dental scalers, lithotripsy systems, and nebulizers. The technology’s reliability is particularly valuable in minimally invasive procedures where accuracy and compact design are critical.

Growth is underpinned by the rise of smart medical devices and a surge in demand for non‑invasive therapeutic solutions. Continued material‑science breakthroughs are improving performance, while collaborations between device manufacturers and piezoceramic specialists are fostering innovation across the sector.

Piezoceramic Components for Medical Market – View in Detailed Research Report

---

Market Size and Growth

In 2025, the market generated USD 155.2 million. Forecast figures indicate a near‑doubling of value to USD 310.6 million by 2034, driven by the integration of piezoceramic elements in a broader array of diagnostic and therapeutic devices.

Product Definition

Piezoceramic components are engineered ceramics that produce controlled mechanical vibrations when stimulated by an electrical signal. Their ability to generate high‑frequency oscillations with minimal energy consumption underpins their use in precision medical tools, from imaging transducers to implantable actuators.

---

Top 10 Companies in the Piezoceramic Components for Medical Market

10. Meggitt Sensing Systems

Headquarters: United Kingdom
Key Offering: High‑precision piezoceramic transducers for surgical robotics and implantable sensors.

Meggitt has built a reputation for delivering robust, low‑noise components that meet stringent regulatory standards. Its focus on integrating real‑time monitoring capabilities positions the company at the forefront of smart surgical systems.

Sustainability & Growth Initiatives: Commitment to reducing lead‑based materials and investing in lead‑free alternatives.

• Partnerships with robotics OEMs to embed sensors in autonomous surgical platforms.
• Continuous improvement of biocompatibility through material optimisation.
• Expansion of global service network to support high‑volume deployments.

9. MSI Transducers

Headquarters: United States
Key Offering: Customisable piezoceramic modules for ultrasound imaging and therapeutic devices.

MSI’s flexible manufacturing approach enables rapid prototyping for niche medical applications, reducing time‑to‑market for emerging devices.

Sustainability & Growth Initiatives: Adoption of additive ceramic printing to lower material waste.

• Collaboration with research institutions to explore novel piezoelectric composites.
• Investment in clean‑room infrastructure to meet global certification requirements.
• Strategic alliances with medical device start‑ups for co‑development projects.

8. TRS Technologies

Headquarters: United States
Key Offering: Integrated sensor‑actuator modules for implantable drug delivery and monitoring systems.

TRS leverages its acquisition of boutique ceramic firms to provide high‑performance components tailored to the medical sector.

Sustainability & Growth Initiatives: Focus on reducing carbon footprint through energy‑efficient manufacturing.

• Partnerships with global OEMs to embed modules in next‑generation implantable devices.
• Development of modular platforms that support rapid customization.
• Expansion of supply chain resilience through diversified material sourcing.

7. Piezo Technologies

Headquarters: United States
Key Offering: Smart piezoceramic transducers for diagnostic imaging and therapeutic ultrasound.

Piezo Technologies has positioned itself as a leader in high‑frequency bandwidth components, enabling advanced image reconstruction algorithms.

Sustainability & Growth Initiatives: Investment in AI‑driven design optimisation.

• Collaboration with imaging vendors to embed AI capabilities.
• R&D into lead‑free, biocompatible ceramic formulations.
• Global expansion of distribution channels across North America and Asia‑Pacific.

6. PI Ceramic

Headquarters: United States
Key Offering: Cost‑effective piezoceramic components for minimally invasive tools.

PI Ceramic’s strong R&D pipeline focuses on enhancing sensitivity while maintaining low production costs, appealing to a broad spectrum of medical device manufacturers.

Sustainability & Growth Initiatives: Commitment to lead‑free manufacturing and regulatory compliance.

• Strategic partnerships with OEMs to embed components in diagnostic platforms.
• Investment in advanced sintering technologies to improve performance.
• Expansion of service and support infrastructure in emerging markets.

5. CTS Corporation

Headquarters: United States
Key Offering: Commercial‑grade piezoceramic transducers for ultrasound and lithotripsy systems.

CTS’s extensive production capacity allows it to supply high volumes to large OEMs, supporting rapid adoption of new medical technologies.

Sustainability & Growth Initiatives: Focus on reducing lead content and improving energy efficiency.

• Collaboration with research institutions to develop next‑generation materials.
• Investment in clean‑room facilities to meet global certification standards.
• Expansion of global supply chain resilience.

4. Johnson Matthey

Headquarters: United Kingdom
Key Offering: High‑performance piezoceramic components for surgical robotics and precision instrumentation.

Johnson Matthey’s long history in advanced materials translates into reliable, high‑quality components that meet stringent regulatory requirements.

Sustainability & Growth Initiatives: Development of environmentally friendly ceramic formulations.

• Partnerships with robotics OEMs to embed sensors in autonomous systems.
• Investment in biocompatible material research.
• Expansion of service capabilities in emerging markets.

3. Fuji Ceramics Corporation

Headquarters: Japan
Key Offering: Integrated sensor‑actuator modules for implantable and wearable medical devices.

Fuji’s expertise in precision ceramic manufacturing supports the development of high‑performance, miniaturised components for next‑generation medical devices.

Sustainability & Growth Initiatives: Focus on reducing lead content and improving material recyclability.

• Collaboration with medical device manufacturers for co‑development of implantable sensors.
• Investment in advanced sintering and additive manufacturing processes.
• Expansion of global distribution network.

2. CeramTec

Headquarters: Germany
Key Offering: PMN‑based piezoceramics for high‑frequency diagnostic transducers and precision actuators.

CeramTec’s focus on high‑performance materials supports the development of next‑generation ultrasound imaging systems and robotic‑assisted surgical tools.

Sustainability & Growth Initiatives: Development of lead‑free, high‑coupling ceramic compositions.

• Strategic partnerships with European OEMs to embed components in advanced medical devices.
• Investment in research facilities to accelerate material innovation.
• Expansion of service and support across the European market.

1. Kyocera

Headquarters: Japan
Key Offering: PZT‑based piezoceramic transducers for lithotripsy systems, inhalers, and ultrasound imaging.

Kyocera’s deep expertise in PZT production and established global distribution network make it a key supplier for high‑volume medical device manufacturers.

Sustainability & Growth Initiatives: Commitment to lead‑free manufacturing and energy‑efficient production processes.

• Collaboration with OEMs to embed components in next‑generation diagnostic platforms.
• Investment in advanced sintering furnaces to improve material quality.
• Expansion of service capabilities in North America and Asia‑Pacific.

---

Download FREE Sample Report: Piezoceramic Components for Medical Market – View in Detailed Research Report

Get Full Report: Piezoceramic Components for Medical Market – View in Detailed Research Report

---

Outlook

From 2025 through 2034, the market is expected to maintain a steady expansion as healthcare providers continue to integrate piezoceramic components into new diagnostic and therapeutic devices. The continued emphasis on miniaturisation and high‑frequency performance will drive demand for advanced materials, while regulatory clarity and global supply chain resilience will support consistent growth.

Future Trends

• Integration of piezoceramic transducers with AI‑driven imaging algorithms to deliver higher resolution diagnostics.
• Expansion of smart prosthetics and wearable sensors that rely on miniaturised piezoceramic actuators for haptic feedback.
• Growing focus on lead‑free, biocompatible formulations to meet environmental and regulatory expectations.
• Increased collaboration between material scientists and device manufacturers to accelerate the development of next‑generation piezoceramic solutions.